Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Abortion, Induced | 19 | 2023 | 85 | 5.830 |
Why?
|
| Pregnancy | 37 | 2024 | 1549 | 2.430 |
Why?
|
| Contraception | 7 | 2023 | 57 | 2.210 |
Why?
|
| Robotics | 4 | 2023 | 41 | 2.090 |
Why?
|
| Abortion, Spontaneous | 3 | 2022 | 24 | 2.050 |
Why?
|
| Contraception Behavior | 4 | 2020 | 32 | 1.650 |
Why?
|
| Papillomavirus Vaccines | 5 | 2024 | 151 | 1.350 |
Why?
|
| Postal Service | 3 | 2022 | 12 | 1.190 |
Why?
|
| Intrauterine Devices | 4 | 2020 | 18 | 1.160 |
Why?
|
| Hawaii | 22 | 2024 | 1929 | 1.130 |
Why?
|
| Female | 47 | 2024 | 20969 | 1.060 |
Why?
|
| Abortifacient Agents | 2 | 2021 | 11 | 0.970 |
Why?
|
| Health Services Accessibility | 2 | 2021 | 560 | 0.930 |
Why?
|
| Young Adult | 22 | 2023 | 4268 | 0.930 |
Why?
|
| Contraceptive Agents, Female | 3 | 2020 | 23 | 0.920 |
Why?
|
| Adolescent | 21 | 2024 | 5363 | 0.910 |
Why?
|
| Telemedicine | 3 | 2021 | 182 | 0.900 |
Why?
|
| Gestational Age | 6 | 2019 | 190 | 0.860 |
Why?
|
| Uterine Hemorrhage | 4 | 2019 | 13 | 0.860 |
Why?
|
| Fetal Research | 1 | 2022 | 4 | 0.840 |
Why?
|
| Fentanyl | 1 | 2022 | 9 | 0.840 |
Why?
|
| Mercury | 3 | 2024 | 39 | 0.830 |
Why?
|
| Home Childbirth | 1 | 2022 | 3 | 0.830 |
Why?
|
| Qualitative Research | 6 | 2023 | 446 | 0.820 |
Why?
|
| Humans | 51 | 2024 | 37093 | 0.820 |
Why?
|
| Adult | 29 | 2024 | 11712 | 0.810 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2022 | 43 | 0.790 |
Why?
|
| Papillomavirus Infections | 4 | 2024 | 336 | 0.760 |
Why?
|
| Intrauterine Devices, Medicated | 2 | 2018 | 11 | 0.750 |
Why?
|
| Levonorgestrel | 2 | 2018 | 16 | 0.750 |
Why?
|
| Sexually Transmitted Diseases | 2 | 2019 | 164 | 0.730 |
Why?
|
| Pregnancy, Unplanned | 2 | 2020 | 29 | 0.710 |
Why?
|
| Fetal Blood | 3 | 2015 | 50 | 0.700 |
Why?
|
| Choice Behavior | 1 | 2020 | 79 | 0.680 |
Why?
|
| Social Values | 2 | 2016 | 30 | 0.670 |
Why?
|
| Seafood | 3 | 2024 | 23 | 0.670 |
Why?
|
| Insurance, Health | 3 | 2023 | 126 | 0.660 |
Why?
|
| Physicians | 1 | 2020 | 163 | 0.640 |
Why?
|
| Condoms | 1 | 2019 | 135 | 0.640 |
Why?
|
| Attitude to Health | 1 | 2021 | 325 | 0.630 |
Why?
|
| Insurance Coverage | 2 | 2015 | 100 | 0.630 |
Why?
|
| Laminaria | 1 | 2017 | 3 | 0.610 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2017 | 6 | 0.610 |
Why?
|
| Postpartum Period | 1 | 2018 | 66 | 0.600 |
Why?
|
| Reminder Systems | 1 | 2017 | 13 | 0.590 |
Why?
|
| Postnatal Care | 1 | 2017 | 13 | 0.580 |
Why?
|
| Attitude of Health Personnel | 2 | 2017 | 198 | 0.580 |
Why?
|
| Family Planning Services | 2 | 2018 | 30 | 0.570 |
Why?
|
| Pregnancy Trimester, Second | 2 | 2017 | 16 | 0.550 |
Why?
|
| Family Planning Policy | 1 | 2015 | 1 | 0.540 |
Why?
|
| Family Practice | 2 | 2016 | 49 | 0.540 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2017 | 864 | 0.520 |
Why?
|
| Oxytocin | 3 | 2022 | 25 | 0.520 |
Why?
|
| Pediatrics | 1 | 2015 | 68 | 0.490 |
Why?
|
| Diabetes, Gestational | 3 | 2023 | 47 | 0.490 |
Why?
|
| Medicaid | 1 | 2015 | 109 | 0.480 |
Why?
|
| United States | 8 | 2023 | 4223 | 0.470 |
Why?
|
| Income | 1 | 2014 | 140 | 0.450 |
Why?
|
| Double-Blind Method | 4 | 2022 | 286 | 0.420 |
Why?
|
| Misoprostol | 6 | 2022 | 26 | 0.420 |
Why?
|
| Cesarean Section | 2 | 2011 | 55 | 0.410 |
Why?
|
| Balloon Occlusion | 1 | 2011 | 3 | 0.400 |
Why?
|
| Dilatation and Curettage | 1 | 2011 | 4 | 0.400 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2011 | 7 | 0.400 |
Why?
|
| Feeding Behavior | 1 | 2014 | 454 | 0.360 |
Why?
|
| Oxytocics | 3 | 2019 | 8 | 0.360 |
Why?
|
| Analgesics | 2 | 2022 | 54 | 0.360 |
Why?
|
| Logistic Models | 4 | 2022 | 923 | 0.350 |
Why?
|
| Selenium | 2 | 2024 | 148 | 0.310 |
Why?
|
| Diet | 1 | 2014 | 801 | 0.300 |
Why?
|
| Blood Loss, Surgical | 2 | 2018 | 13 | 0.300 |
Why?
|
| Pain | 2 | 2022 | 251 | 0.300 |
Why?
|
| Mifepristone | 3 | 2022 | 34 | 0.290 |
Why?
|
| Patient Satisfaction | 2 | 2017 | 145 | 0.280 |
Why?
|
| Abortifacient Agents, Nonsteroidal | 3 | 2021 | 9 | 0.280 |
Why?
|
| Students, Medical | 2 | 2018 | 130 | 0.260 |
Why?
|
| Ibuprofen | 2 | 2022 | 32 | 0.260 |
Why?
|
| Child | 4 | 2024 | 3131 | 0.250 |
Why?
|
| Magnetics | 2 | 2022 | 36 | 0.250 |
Why?
|
| Pregnancy in Adolescence | 2 | 2016 | 32 | 0.240 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2020 | 404 | 0.240 |
Why?
|
| Physical Phenomena | 1 | 2023 | 2 | 0.230 |
Why?
|
| Heating | 1 | 2023 | 4 | 0.230 |
Why?
|
| Body Temperature Regulation | 1 | 2023 | 8 | 0.230 |
Why?
|
| Male | 13 | 2024 | 20025 | 0.220 |
Why?
|
| Elastomers | 1 | 2022 | 3 | 0.220 |
Why?
|
| Motion | 1 | 2022 | 27 | 0.210 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2022 | 4 | 0.210 |
Why?
|
| Aborted Fetus | 1 | 2022 | 5 | 0.210 |
Why?
|
| Pelvic Pain | 1 | 2022 | 9 | 0.210 |
Why?
|
| Pregnancy Trimester, First | 1 | 2022 | 17 | 0.210 |
Why?
|
| Parturition | 1 | 2022 | 24 | 0.210 |
Why?
|
| Patient-Centered Care | 1 | 2022 | 63 | 0.200 |
Why?
|
| Intraoperative Complications | 2 | 2019 | 18 | 0.200 |
Why?
|
| Drug and Narcotic Control | 1 | 2021 | 10 | 0.200 |
Why?
|
| Abortifacient Agents, Steroidal | 1 | 2021 | 3 | 0.200 |
Why?
|
| United States Food and Drug Administration | 1 | 2021 | 22 | 0.200 |
Why?
|
| Confidentiality | 1 | 2021 | 26 | 0.190 |
Why?
|
| Treatment Outcome | 2 | 2018 | 1369 | 0.190 |
Why?
|
| Contraceptive Agents | 1 | 2020 | 13 | 0.190 |
Why?
|
| Postoperative Complications | 2 | 2019 | 210 | 0.180 |
Why?
|
| Drug Delivery Systems | 1 | 2022 | 202 | 0.180 |
Why?
|
| Infant, Newborn | 2 | 2022 | 894 | 0.180 |
Why?
|
| Sterilization, Tubal | 1 | 2020 | 3 | 0.180 |
Why?
|
| Case-Control Studies | 2 | 2022 | 1130 | 0.180 |
Why?
|
| Electric Capacitance | 1 | 2019 | 7 | 0.180 |
Why?
|
| Textiles | 1 | 2019 | 4 | 0.180 |
Why?
|
| Foot | 1 | 2019 | 10 | 0.170 |
Why?
|
| Data Collection | 1 | 2019 | 194 | 0.170 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2018 | 14 | 0.170 |
Why?
|
| Communication | 2 | 2017 | 180 | 0.170 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2019 | 33 | 0.160 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2019 | 113 | 0.160 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2018 | 33 | 0.160 |
Why?
|
| Hemostatics | 1 | 2018 | 8 | 0.160 |
Why?
|
| Health Personnel | 1 | 2020 | 228 | 0.160 |
Why?
|
| Sodium Bicarbonate | 1 | 2017 | 8 | 0.150 |
Why?
|
| Lidocaine | 1 | 2017 | 17 | 0.150 |
Why?
|
| Age Factors | 2 | 2018 | 1033 | 0.150 |
Why?
|
| Middle Aged | 4 | 2021 | 10129 | 0.150 |
Why?
|
| Dilatation | 1 | 2017 | 4 | 0.150 |
Why?
|
| Delivery, Obstetric | 1 | 2017 | 40 | 0.150 |
Why?
|
| Self-Examination | 1 | 2017 | 9 | 0.150 |
Why?
|
| Decision Making | 1 | 2019 | 203 | 0.150 |
Why?
|
| Feasibility Studies | 1 | 2018 | 208 | 0.150 |
Why?
|
| Counseling | 3 | 2023 | 116 | 0.140 |
Why?
|
| Pain Measurement | 1 | 2017 | 171 | 0.140 |
Why?
|
| Pamphlets | 1 | 2016 | 26 | 0.140 |
Why?
|
| Parents | 2 | 2016 | 329 | 0.140 |
Why?
|
| Electronic Health Records | 1 | 2017 | 66 | 0.140 |
Why?
|
| Sexual Partners | 1 | 2019 | 314 | 0.140 |
Why?
|
| Trust | 1 | 2017 | 133 | 0.140 |
Why?
|
| Population Groups | 1 | 2016 | 56 | 0.140 |
Why?
|
| Family Relations | 1 | 2015 | 46 | 0.130 |
Why?
|
| Pilot Projects | 1 | 2018 | 661 | 0.130 |
Why?
|
| Cross-Sectional Studies | 4 | 2017 | 2721 | 0.130 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 974 | 0.130 |
Why?
|
| Animals | 5 | 2024 | 15081 | 0.130 |
Why?
|
| Family Characteristics | 1 | 2015 | 108 | 0.120 |
Why?
|
| Philippines | 1 | 2014 | 73 | 0.120 |
Why?
|
| Retrospective Studies | 5 | 2021 | 2026 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 643 | 0.120 |
Why?
|
| Pacific Islands | 1 | 2014 | 119 | 0.120 |
Why?
|
| Focus Groups | 1 | 2015 | 348 | 0.120 |
Why?
|
| Japan | 1 | 2014 | 305 | 0.110 |
Why?
|
| Vaccination | 1 | 2015 | 288 | 0.110 |
Why?
|
| Overweight | 1 | 2015 | 247 | 0.110 |
Why?
|
| Social Support | 1 | 2015 | 394 | 0.110 |
Why?
|
| Residence Characteristics | 1 | 2015 | 322 | 0.110 |
Why?
|
| Selenoproteins | 1 | 2015 | 159 | 0.110 |
Why?
|
| Obesity | 2 | 2017 | 1067 | 0.100 |
Why?
|
| Vitamin D Deficiency | 1 | 2013 | 105 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 803 | 0.100 |
Why?
|
| Vitamin D | 1 | 2013 | 196 | 0.090 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2021 | 33 | 0.090 |
Why?
|
| Health Promotion | 1 | 2016 | 653 | 0.090 |
Why?
|
| Fishes | 2 | 2024 | 53 | 0.090 |
Why?
|
| Pregnancy Outcome | 1 | 2010 | 87 | 0.090 |
Why?
|
| Placenta | 2 | 2024 | 97 | 0.090 |
Why?
|
| Neoplasms | 1 | 2018 | 1103 | 0.080 |
Why?
|
| Abortion, Legal | 1 | 2023 | 6 | 0.060 |
Why?
|
| Selenocysteine | 1 | 2024 | 55 | 0.060 |
Why?
|
| Flowers | 1 | 2023 | 16 | 0.060 |
Why?
|
| Pharmacists | 1 | 2024 | 53 | 0.060 |
Why?
|
| Asia | 1 | 2023 | 75 | 0.060 |
Why?
|
| Cysteine | 1 | 2024 | 98 | 0.060 |
Why?
|
| Gender Identity | 1 | 2024 | 103 | 0.060 |
Why?
|
| Holistic Health | 1 | 2023 | 13 | 0.050 |
Why?
|
| Electricity | 1 | 2022 | 9 | 0.050 |
Why?
|
| Needs Assessment | 1 | 2024 | 170 | 0.050 |
Why?
|
| Oxycodone | 1 | 2022 | 4 | 0.050 |
Why?
|
| Acetaminophen | 1 | 2022 | 27 | 0.050 |
Why?
|
| Risk Reduction Behavior | 1 | 2023 | 127 | 0.050 |
Why?
|
| Locomotion | 1 | 2022 | 97 | 0.050 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2021 | 4 | 0.050 |
Why?
|
| Microtechnology | 1 | 2021 | 5 | 0.050 |
Why?
|
| Biomimetics | 1 | 2021 | 10 | 0.050 |
Why?
|
| Aftercare | 1 | 2021 | 19 | 0.050 |
Why?
|
| Biomimetic Materials | 1 | 2021 | 23 | 0.050 |
Why?
|
| Equipment Design | 1 | 2021 | 124 | 0.050 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 2020 | 12 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 197 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2020 | 325 | 0.040 |
Why?
|
| Blood Volume | 1 | 2019 | 5 | 0.040 |
Why?
|
| Reference Values | 1 | 2019 | 212 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2023 | 400 | 0.040 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2018 | 23 | 0.040 |
Why?
|
| Methylergonovine | 1 | 2018 | 3 | 0.040 |
Why?
|
| Minority Groups | 1 | 2023 | 596 | 0.040 |
Why?
|
| Vasopressins | 1 | 2018 | 13 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2019 | 291 | 0.040 |
Why?
|
| Patient Care Planning | 1 | 2017 | 14 | 0.040 |
Why?
|
| Gynecology | 1 | 2018 | 31 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2019 | 550 | 0.040 |
Why?
|
| Obstetrics | 1 | 2018 | 37 | 0.040 |
Why?
|
| Vacuum Extraction, Obstetrical | 1 | 2017 | 5 | 0.040 |
Why?
|
| Parity | 1 | 2017 | 46 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2017 | 55 | 0.040 |
Why?
|
| Prevalence | 2 | 2013 | 1455 | 0.040 |
Why?
|
| Physician-Patient Relations | 1 | 2017 | 128 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 885 | 0.040 |
Why?
|
| Sex Education | 1 | 2016 | 30 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2016 | 136 | 0.030 |
Why?
|
| Community Networks | 1 | 2016 | 108 | 0.030 |
Why?
|
| Health Surveys | 1 | 2017 | 373 | 0.030 |
Why?
|
| Peer Group | 1 | 2016 | 156 | 0.030 |
Why?
|
| Program Development | 1 | 2016 | 233 | 0.030 |
Why?
|
| Time Factors | 1 | 2019 | 1742 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2016 | 339 | 0.030 |
Why?
|
| Adolescent Behavior | 1 | 2016 | 253 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2013 | 33 | 0.030 |
Why?
|
| Health Education | 1 | 2016 | 338 | 0.030 |
Why?
|
| Lactation | 1 | 2013 | 40 | 0.030 |
Why?
|
| Sunlight | 1 | 2013 | 47 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 859 | 0.030 |
Why?
|
| Seasons | 1 | 2013 | 112 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 225 | 0.020 |
Why?
|
| Sexual Behavior | 1 | 2016 | 609 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2013 | 208 | 0.020 |
Why?
|
| Maternal Age | 1 | 2010 | 26 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1207 | 0.020 |
Why?
|
| Mice | 1 | 2021 | 5913 | 0.020 |
Why?
|
| Micronesia | 1 | 2010 | 80 | 0.020 |
Why?
|
| Age Distribution | 1 | 2010 | 225 | 0.020 |
Why?
|
| Birth Weight | 1 | 2010 | 90 | 0.020 |
Why?
|
| Infant | 1 | 2013 | 1046 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 1067 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2013 | 1378 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2010 | 353 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2010 | 854 | 0.020 |
Why?
|
| Aged | 1 | 2016 | 6741 | 0.020 |
Why?
|
| Risk Factors | 1 | 2010 | 3562 | 0.010 |
Why?
|